Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Hi, what are you looking for?
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
BioLight also announced that a new private investor participated in the private placement with the same terms in the amount of $350, 000.
"Spain came out saying they would make a law but Portugal did it first and it's easier in Portugal."
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Moving to a Poor Neighborhood Can Cause Weight Gain, according to a new study
The measles virus is known to cast a deadly shadow upon children by temporarily suppressing their immune systems. While this vulnerability was previously thought...
Your genes may influence how sensitive you are to emotional information, according to new research by a UBC neuroscientist. The study, recently published in...
eShop is a platform for people with diabetes to directly purchase Dario & get support,
Nonalcoholic Steatohepatitis is a progressive liver disease associated with increased risk for liver cirrhosis, hepatocellular cancer, metabolic and cardiovascular disease .